|
SNX12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.21520587931445E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63125069008174E-12 |
| Normal-vs-Stage2 |
1.284820E-03 |
| Normal-vs-Stage3 |
5.983100E-03 |
| Normal-vs-Stage4 |
4.963300E-04 |
| Stage1-vs-Stage2 |
2.390800E-01 |
| Stage1-vs-Stage3 |
1.590120E-02 |
| Stage1-vs-Stage4 |
5.188400E-01 |
| Stage2-vs-Stage3 |
5.009000E-01 |
| Stage2-vs-Stage4 |
2.496400E-01 |
| Stage3-vs-Stage4 |
9.800400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.76996261670138E-14 |
| Normal-vs-AfricanAmerican |
2.42770004099668E-09 |
| Normal-vs-Asian |
4.730400E-02 |
| Caucasian-vs-AfricanAmerican |
6.650600E-01 |
| Caucasian-vs-Asian |
9.406600E-01 |
| AfricanAmerican-vs-Asian |
9.414000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62647673107585E-12 |
| Normal-vs-Female |
3.768000E-04 |
| Male-vs-Female |
3.88300000000452E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.72300000045311E-07 |
| Normal-vs-Extreme_Weight |
1.6251444634463E-12 |
| Normal-vs-Obese |
3.22140000008631E-07 |
| Normal-vs-Extreme_Obese |
9.65330000379794E-08 |
| Normal_Weight-vs-Extreme_Weight |
2.654200E-01 |
| Normal_Weight-vs-Obese |
2.952000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.096600E-01 |
| Extreme_Weight-vs-Obese |
7.222000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.186200E-01 |
| Obese-vs-Extreme_Obese |
1.710570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.301300E-03 |
| Normal-vs-Age(41-60Yrs) |
9.47130041062394E-10 |
| Normal-vs-Age(61-80Yrs) |
3.5527136788005E-15 |
| Normal-vs-Age(81-100Yrs) |
2.28869999618908E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.051400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.100300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.109240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.156000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.209400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.186800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.88178419700125E-16 |
| Normal-VS-Type2 PRCC |
1.19430000000698E-07 |
| Normal-VS-KIRP CIMP |
2.708400E-02 |
| Normal-VS-Unclassified PRCC |
4.397400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.496700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.007360E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.283200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.589000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.386200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.829000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.99800000380657E-08 |
| Normal-vs-N1 |
4.09900000000185E-05 |
| Normal-vs-N2 |
1.492000E-02 |
| N0-vs-N1 |
7.226800E-01 |
| N0-vs-N2 |
5.831200E-01 |
| N1-vs-N2 |
6.658000E-01 |
|
|
